Tumor necrosis factor-alpha (TNF-α) antagonists have advanced treatment of psoriasis and other chronic inflammatory diseases but are not free of adverse effects. Pyogenic granuloma is yet described in literature as a dermatological side effect of multiple drugs such as retinoids, antiretroviral, and antineoplastic drugs but, to the best of our knowledge, it has never been reported among the adverse skin reactions following anti-TNF-α therapy. We report on a 20-year-old Caucasian man with psoriatic arthritis who developed multiple eruptive periungual and subungual pyogenic granulomas following treatment with TNF-α antagonist etanercept. ©
Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: is it the first case? / Patruno, Cataldo; Balato, Nicola; Cirillo, T; Napolitano, M; Ayala, Fabio. - In: DERMATOLOGIC THERAPY. - ISSN 1396-0296. - 26:(2013), pp. 493-495. [10.1111/dth.12022]
Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: is it the first case?
PATRUNO, CATALDO;BALATO, NICOLA;Napolitano M;AYALA, FABIO
2013
Abstract
Tumor necrosis factor-alpha (TNF-α) antagonists have advanced treatment of psoriasis and other chronic inflammatory diseases but are not free of adverse effects. Pyogenic granuloma is yet described in literature as a dermatological side effect of multiple drugs such as retinoids, antiretroviral, and antineoplastic drugs but, to the best of our knowledge, it has never been reported among the adverse skin reactions following anti-TNF-α therapy. We report on a 20-year-old Caucasian man with psoriatic arthritis who developed multiple eruptive periungual and subungual pyogenic granulomas following treatment with TNF-α antagonist etanercept. ©| File | Dimensione | Formato | |
|---|---|---|---|
|
Periungual and subungual pyogenic granuloma following anti-TNF-alpha therapy is it the first case.pdf
non disponibili
Tipologia:
Abstract
Licenza:
Accesso privato/ristretto
Dimensione
65.65 kB
Formato
Adobe PDF
|
65.65 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
